نتایج جستجو برای: percutaneous intervention
تعداد نتایج: 286015 فیلتر نتایج به سال:
Time and time again, randomized clinical trials have demonstrated that what is conceptually logical and should be right is not always right. Randomized large clinical trials are often undertaken on the basis of this logical hypothesis. Very often, small clinical trials also show encouraging results.1,2 However, when large randomized clinical trials are performed, they not infrequently reveal ra...
Few situations in clinical medicine are as disheartening to patients, family, healthcare providers, and healthcare systems as readmission to the hospital shortly after discharge. Such events lead to a not-unexpected plethora of questions. From the patient and family: “What went wrong?” From the provider: “What did I do wrong?” From the healthcare system: “How do we prevent this from happening a...
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is a rapidly developing field. In the present review, we summarize the most important CTO PCI related literature published in 2013.
In the article titled “Administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention.” [1], the name of the first author was given incorrectly as Sadegh Ali-Hassan-Sayegh. The author's name should have been written as Sadeq Ali-Hasan-Al-Saegh. The revised authors' list is shown above. These two spelling are belonging to an author. The authors would ...
The CYP2C19*2 loss-of-function allele is associated with reduced generation of active metabolites of clopidogrel. However, meta-analyses have supported or discounted the impact of genotype on adverse cardiovascular outcomes during clopidogrel therapy, depending on studies included in the analysis. Here we review these data and conclude that evidence supports a differential effect of genotype on...
Percutaneous coronary intervention (PCI) outcomes of chronic total occlusions (CTO) lesions have improved in recent years due to a better understanding of the physiopathology of the disease, more effective techniques and improvement in the design of new devices. We describe a new use of the Tornus® Catheter in the anterograde approach for CTO treatment.
5
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید